Oceania · General news · The Australian

TrivarX takes key step towards trial of next-gen cancer imaging technology

Published by The Australian · Australia 10 h ago

TrivarX has enlisted pharmaceutical specialist Syntro Health to help prepare its Stabl-Im imaging technology for clinical trials starting in 2027.

Read the full article on The Australian Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.theaustralian.com.au)

Also worth reading

Global study prompts warning over Queensland’s falling vaccination rates

Global study prompts warning over Queensland’s falling vaccination rates

The Fifth Estate

The ambitious Arden Central project has been revealed – it will take 30 years and $7 billion to realise

Seven's Helen Haines cross

pv magazine Australia

80.9 GW quarterly pipeline of clean energy projects surpasses current 77 GW capacity

ABC News Australia

Schutt banned for two matches after prescription medication failure